Ovid Therapeutics
OVID
OVID
35 hedge funds and large institutions have $18.7M invested in Ovid Therapeutics in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
81% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 16
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$820K | |
| 2 | +$644K | |
| 3 | +$537K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$238K |
| 5 |
Renaissance Technologies
New York
|
+$200K |
Top Sellers
| 1 | -$3.15M | |
| 2 | -$973K | |
| 3 | -$457K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$398K |
| 5 |
State Street
Boston,
Massachusetts
|
-$333K |